ELI LILLY AND COMPANY LIMITED
Company Information
- Company Number
- 00284385
- Registered Address
- Eli Lilly And Company Limited, Lilly House, Basingview, Basingstoke, Hampshire, United Kingdom, RG21 4FA
- Status
- Active
- Employee Count
- 595
- Turnover
- £443,146,000
- EBITDA
- £12,809,000
Additional Details
- Website
- https://www.lilly.com/
- Company Type
- Private limited Company
- Incorporated On
- 5 February 1934
- Nature of Business
- 21100 - Manufacture of basic pharmaceutical products
- Industries
- Life Sciences And Medical Technology
- Region
- South East
Time to Pay
Payment Timeline
Payment Features
Payment Score History
Performance Reports History
| Reporting Period | Filing Date | Average Time to Pay (days) | Paid within 30 days | Paid 31-60 days | Paid after 60 days | Not Paid within Terms |
|---|---|---|---|---|---|---|
| 01 Jan 2025 - 30 Jun 2025 | 30 Jul 2025 | 31 | 54% | 44% | 2% | 17% |
| 01 Jul 2024 - 31 Dec 2024 | 31 Jan 2025 | 28 | 59% | 39% | 2% | 18% |
| 01 Jul 2023 - 31 Dec 2023 | 30 Jan 2024 | 30 | 59% | 39% | 2% | 21% |
| 01 Jan 2023 - 30 Jun 2023 | 27 Jul 2023 | 30 | 56% | 42% | 2% | 22% |
| 01 Jul 2022 - 31 Dec 2022 | 26 Jan 2023 | 27 | 61% | 37% | 2% | 27% |
| 01 Jan 2022 - 30 Jun 2022 | 29 Jul 2022 | 30 | 59% | 39% | 2% | 28% |
| 01 Jul 2021 - 31 Dec 2021 | 01 Feb 2022 | 26 | 66% | 32% | 2% | 22% |
| 01 Jan 2021 - 30 Jun 2021 | 27 Jul 2021 | 27 | 66% | 31% | 3% | 21% |
| 01 Jan 2020 - 30 Jun 2020 | 30 Jul 2020 | 29 | 67% | 31% | 2% | 23% |
| 01 Jul 2019 - 31 Dec 2019 | 27 Jan 2020 | 23 | 72% | 27% | 1% | 29% |
| 01 Jan 2019 - 30 Jun 2019 | 25 Jul 2019 | 21 | 77% | 22% | 1% | 34% |
| 01 Jan 2018 - 30 Jun 2018 | 26 Jul 2018 | 25 | 68% | 30% | 2% | 47% |
Payment Time Trends
Payment Distribution Trends
Invoice Payment Practices
This information is as reported by the business, and responses are in their own words.
Payment Terms
Standard payment terms
Standard contractual terms for goods and services is 60 days. Healthcare Professionals are paid 10 days from invoice date. Affiliate companies are paid on the 15th of the month following.
Were there any changes to the standard payment terms in the reporting period?
No information available
Any other information about payment terms
N/a
Maximum contractual payment period agreed
60
Dispute Resolution Process
Vendors for UK, Ireland, Nordics, France, Germany and Spain can upload and view the status of their invoices and purchase orders on our online portal, Ariba. All Invoice and payment queries are first directed to our outsourced Accounts Payable Business Partner, who have 48hrs to respond. Unresolved queries are then escalated to the internal Exception Handling Team, who have a further 48hrs to respond. If a resolution is still not reached it is then escalated to the internal Single Point of Contact Team. If an invoice is sent in without a purchase order it is returned to the vendor, to be resent with a purchase order number.
Other Payment Information
Has this business signed up to a code of conduct or standards on payment practices?
For example, signatories to The Prompt Payment Code must commit to paying 95% of their invoices within 60 days.
❌
Does this business offer e-invoicing in relation to qualifying contracts?
This is where suppliers can electronically submit and track invoices. It's not just allowing suppliers to email them an invoice.
❌
Does this business offer supply chain finance?
This is where a supplier who has submitted an invoice can be paid by a third-party finance provider earlier than the agreed payment date. The business would then pay the finance provider the invoiced sum.
❌
Under its payment practices and policies, can this business deduct sums from payments under qualifying contracts as a charge for remaining on a supplier list?
❌
During the reporting period, did the business deduct sums from payments as a charge for remaining on a supplier list?
No information available
Company Summary
ELI LILLY AND COMPANY LIMITED is a global pharmaceutical company that specializes in the research, development, and production of innovative medicines to improve the lives of people around the world. Founded in 1876, the company has a long history of providing effective and safe healthcare solutions.
The company's sustainability program focuses on three key areas: reducing environmental impact, enhancing access to medicines, and promoting diversity and inclusion. They have set ambitious goals to reduce their carbon footprint, water usage, and waste generation. They also work with local communities to improve access to healthcare, especially in developing countries. In addition, they have initiatives to promote diversity and inclusion in the workplace, with a goal of achieving gender parity by 2030.
ELI LILLY AND COMPANY LIMITED offers a wide range of products and services in various therapeutic areas such as diabetes, oncology, immunology, and neuroscience. Their portfolio includes both prescription and over-the-counter medicines, as well as medical devices and diagnostic tools. The company is known for its groundbreaking insulin products, as well as other life-saving treatments for various diseases.
The key people at ELI LILLY AND COMPANY LIMITED include David A. Ricks, Chairman and CEO, and Melissa Barnes, Chief Ethics and Compliance Officer. The company is headquartered in Indianapolis, Indiana, USA, and has offices and facilities in more than 70 countries. Their website address is www.lilly.com, and their registered office address is Eli Lilly and Company Limited, Lilly House, Priestley Road, Basingstoke, Hampshire, RG24 9NL, United Kingdom.
In summary, ELI LILLY AND COMPANY LIMITED is a leading pharmaceutical company with a strong commitment to sustainability, innovation, and improving global health. Their diverse portfolio of products and services, along with their dedication to ethical business practices, make them a trusted and respected name in the healthcare industry.
